Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengwen Li

Showing results (81-90 of 190) with videos related to

Pageof 19
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2024
A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapyBrian C Gilger, Tomoko Hasegawa, R Bryan Sutton, et al.
Antibiotics (Basel, Switzerland)|September 19, 2019
Characterization of a Carbapenem-Resistant <i>Kluyvera Cryocrescens</i> Isolate Carrying <i>Bla</i><sub>ndm-1</sub> from Hospital SewageYing Li, Li Luo, Zhijiao Xiao, et al.
Journal of Virology|June 25, 2010
Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transductionJarrod S Johnson, Chengwen Li, Nina DiPrimio, et al.
The Journal of Surgical Research|August 21, 2009
A modified technique for heterotopic heart transplantation in ratsJuan Shan, Yuchuan Huang, Li Feng, et al.
Organic & Biomolecular Chemistry|October 19, 2020
Synthesis of difluoroalkylated 2-azaspiro[4.5]decane derivatives via copper-catalyzed difluoroalkylation/dearomatization of N-benzylacrylamidesChengwen Li, Yilin Zhao, Jiaxin Zhou, et al.
Frontiers in Medicine|August 22, 2022
Adeno-associated virus-mediated expression of activated factor V (FVa) for hemophilia phenotypic correctionJunjiang Sun, Xiaojing Chen, Zheng Chai, et al.
Pharmacology & Therapeutics|December 15, 2019
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene deliveryNatalie F Nidetz, Michael C McGee, Longping V Tse, et al.
European Journal of Immunology|April 7, 2011
Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activityKevin S Goudy, Mark C Johnson, Alaina Garland, et al.
Frontiers in Immunology|March 3, 2020
Corrigendum: Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions <i>In Vivo</i>Xiaolei Pei, Lauriel Freya Earley, Yi He, et al.
Human Gene Therapy|March 29, 2013
Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identicalYi He, Marc S Weinberg, Matt Hirsch, et al.
Pageof 19

Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2024
A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapyBrian C Gilger, Tomoko Hasegawa, R Bryan Sutton, et al.
Antibiotics (Basel, Switzerland)|September 19, 2019
Characterization of a Carbapenem-Resistant <i>Kluyvera Cryocrescens</i> Isolate Carrying <i>Bla</i><sub>ndm-1</sub> from Hospital SewageYing Li, Li Luo, Zhijiao Xiao, et al.
Journal of Virology|June 25, 2010
Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transductionJarrod S Johnson, Chengwen Li, Nina DiPrimio, et al.
The Journal of Surgical Research|August 21, 2009
A modified technique for heterotopic heart transplantation in ratsJuan Shan, Yuchuan Huang, Li Feng, et al.
Organic & Biomolecular Chemistry|October 19, 2020
Synthesis of difluoroalkylated 2-azaspiro[4.5]decane derivatives via copper-catalyzed difluoroalkylation/dearomatization of N-benzylacrylamidesChengwen Li, Yilin Zhao, Jiaxin Zhou, et al.
Frontiers in Medicine|August 22, 2022
Adeno-associated virus-mediated expression of activated factor V (FVa) for hemophilia phenotypic correctionJunjiang Sun, Xiaojing Chen, Zheng Chai, et al.
Pharmacology & Therapeutics|December 15, 2019
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene deliveryNatalie F Nidetz, Michael C McGee, Longping V Tse, et al.
European Journal of Immunology|April 7, 2011
Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activityKevin S Goudy, Mark C Johnson, Alaina Garland, et al.
Frontiers in Immunology|March 3, 2020
Corrigendum: Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions <i>In Vivo</i>Xiaolei Pei, Lauriel Freya Earley, Yi He, et al.
Human Gene Therapy|March 29, 2013
Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identicalYi He, Marc S Weinberg, Matt Hirsch, et al.
Pageof 19